🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ariel Ann Nelson

Medical College of Wisconsin

ORCID: 0000-0003-1429-9018
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Real-world prognostic model for overall survival (OS) in patients (pts) with advanced urothelial cancer (aUC) treated with immune checkpoint inhibitors (ICI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.447
Top 100%
0DataRank
Top 100%0 citations

Leonidas Nikolaos Diamantopoulos, Natalie Miller, Mehmet Asım Bilen, Víctor Sacristán Santos, Rafael Morales‐Barrera +15 more

Papers

Driven by 11 papers — median percentile 0. Top paper: “Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes”.

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

British Journal of Urology(2021)10.1111/bju.15324
N/A
0.505DataRank · unranked
28 citations

Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky +41 more

Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.06.001
N/A
0.505DataRank · unranked
28 citations

Rafee Talukder, Genevieve Ihsiu Lin, Leonidas Nikolaos Diamantopoulos, Scott J. Dawsey, Shilpa Gupta +47 more

Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.08.006
N/A
0.345DataRank · unranked
9 citations

Dimitrios Makrakis, Genevieve Ihsiu Lin, Leonidas Nikolaos Diamantopoulos, Scott J. Dawsey, Shilpa Gupta +49 more

Epidemiology and outcomes of primary pediatric lung malignancies: Updates from the SEER database

The American Journal of Surgery(2021)10.1016/j.amjsurg.2021.01.037
N/A
0DataRank · unranked
12 citations

Devashis Mukherjee, Yu Wang, Ruta Brazauskas, Ariel Ann Nelson, Chandler S. Cortina +1 more

A Perspective on Withania somnifera Modulating Antitumor Immunity in Targeting Prostate Cancer

Journal of Immunology Research(2021)10.1155/2021/9483433
N/A
0DataRank · unranked
11 citations

Manohar Singh, Ariel Ann Nelson, Dev Karan, Seema Dubey

Association of prior local therapy and outcomes with programmed‐death ligand‐1 inhibitors in advanced urothelial cancer

British Journal of Urology(2021)10.1111/bju.15603
N/A
0DataRank · unranked
5 citations

Rafee Talukder, Leonidas Nikolaos Diamantopoulos, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky +42 more

Minding the Bathwater: Fertility and Reproductive Toxicity in the Age of Immuno-Oncology

JCO Oncology Practice(2022)10.1200/op.22.00469
N/A
0DataRank · unranked
25 citations

Ariel Ann Nelson, Kyle Stimpert, Rebecca Flyckt, Nannan Thirumavalavan, Karen Baker +3 more

Histologic subtype and response to immune checkpoint inhibitor (ICI) therapy in advanced urothelial cancer (aUC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.495
N/A
0DataRank · unranked
0 citations

Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos, Mehmet Asım Bilen, Víctor Sacristán Santos, Rafael Morales‐Barrera +15 more

Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma

The Oncologist(2025)10.1093/oncolo/oyaf138
N/A
0DataRank · unranked
0 citations

Neil J. Shah, Matthew T. Campbell, Naomi B. Haas, Ariel Ann Nelson, Moshe Chaim Ornstein +12 more

Real-world prognostic model for overall survival (OS) in patients (pts) with advanced urothelial cancer (aUC) treated with immune checkpoint inhibitors (ICI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.447
Top 100%
0DataRank
Top 100%0 citations

Leonidas Nikolaos Diamantopoulos, Natalie Miller, Mehmet Asım Bilen, Víctor Sacristán Santos, Rafael Morales‐Barrera +15 more

Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial

Practical Radiation Oncology(2021)10.1016/j.prro.2021.03.006
N/A
0DataRank · unranked
6 citations

Meena Bedi, Deepak Kilari, Kathryn Bylow, John Burfeind, Candice Johnstone +8 more